Product
Mometasone Furoate
Aliases
Asmanex, Asmanex® Twisthaler®, Mometasone Furoate Aqueous Nasal Spray, mometasone furoate dry powder inhaler (4 other aliases)
Name
NASONEX
INN Name
Mometasone Furoate
FDA Approved
Yes
15 clinical trials
3 organizations
14 indications
2 documents
Indication
Allergic RhinitisIndication
AsthmaIndication
Atopic DermatitisIndication
Chronic RhinosinusitisIndication
Rhinitis MedicamentosaIndication
Nasal PolypsIndication
Adenoid HypertrophyIndication
Sleep DisorderIndication
SnoringIndication
Obstructive Sleep ApneaIndication
Sleep Disorders in ChildrenIndication
Tonsillar HypertrophyIndication
Adenoidal DisorderIndication
Alopecia AreataClinical trial
Study on the Efficacy and Safety of Bencycloquidium Bromide Nasal Spray Alone or in Combination With Mometasone Furoate Aqueous Nasal Spray in the Treatment of Moderate-severe Persistent Allergic RhinitisStatus: Active (not recruiting), Estimated PCD: 2024-04-30
Clinical trial
A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma (Protocol No. P06241 Also Known as P202)Status: Completed, Estimated PCD: 2016-11-30
Clinical trial
Phase IV Clinical Study,Comparative, Blind Double and Randomized to Compare Mometasone Furoate Cream (TOPISON) Versus Other Two Cream Mometasone Furoate, in Participants With Atopic DermatitisStatus: Completed, Estimated PCD: 2023-07-10
Clinical trial
An Open-label, Single-Dose, Three-way Crossover Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents (12 to 17 Years of Age) and Young Adults (18 to 24 Years of Age) With Seasonal Allergic RhinitisStatus: Terminated, Estimated PCD: 2023-09-08
Clinical trial
Anti-IL4/IL13 Therapy With Dupilumab for Prevention of Refractory Chronic Rhinosinusitis After Endoscopic Sinus Surgery for CRSwNPStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
Characterisation and Intervention Study in Patients With Long-term Use of Nasal DecongestantsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years OldStatus: Completed, Estimated PCD: 2008-06-01
Clinical trial
A Double-blind Placebo-controlled, Randomized, Parallel-group, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy SNORE StudyStatus: Completed, Estimated PCD: 2010-01-01
Clinical trial
A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Mild Persistent and Moderate Persistent Asthmatic PatientsStatus: Completed, Estimated PCD: 2009-07-01
Clinical trial
Efficacy of Intranasal Steroid for Children With Sleep-Disordered Breathing Non-Responsive to Initial Treatment With Intranasal Saline: A Randomized TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata: Clinical, Dermoscopic and Immunohistochemical StudyStatus: Not yet recruiting, Estimated PCD: 2027-10-01
Clinical trial
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma (Phase 2; Protocol No. P04223AM3)Status: Completed, Estimated PCD: 2015-01-29
Clinical trial
A Randomized, Evaluator-Blind, Crossover, Single Dose Study of the Bronchodilator Effect of Formoterol Fumarate in Combination With Mometasone Furoate Metered Dose Inhaler Delivered With and Without a Spacer Versus Placebo and Foradil® Aerolizer® in Children With Persistent Asthma (Protocol No. P06476)Status: Completed, Estimated PCD: 2011-10-01
Clinical trial
A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Low-Dose Inhaled GlucocorticosteroidsStatus: Completed, Estimated PCD: 2008-08-01
Clinical trial
Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Density in Adults With AsthmaStatus: Completed, Estimated PCD: 2009-10-01
Document
DailyMed Label: NASONEXOrganization
Physicians Total Care, Inc.Document
DailyMed Label: AsmanexOrganization
Organon LLCOrganization
Organon LLC